The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · see citing works

Resolvins

Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650 · see citing works

Macrophage death and defective inflammation resolution in atherosclerosis

Tabas, I. (2010) · Nature Reviews Immunology · doi:10.1038/nri2675 · Cited by 1,120 · see citing works

International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family

Ye, R. D., Boulay, F., Wang, J. M., Dahlgren, C., Gerard, C. J., Parmentier, M., Serhan, C. N., & Murphy, P. M. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001578 · Cited by 767 · see citing works

Resolvin D1 binds human phagocytes with evidence for proresolving receptors

Krishnamoorthy, S., Recchiuti, A., Chiang, N., Yacoubian, S., Lee, C., Yang, R., Petasis, N. A., & Serhan, C. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907342107 · Cited by 738 · see citing works

Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans

Libby, P., Lichtman, A. H., & Hansson, G. K. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.009 · Cited by 667 · see citing works

Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E–deficient mice

Cyrus, T., Witztum, J. L., Rader, D. J., Tangirala, R., Fazio, S., Linton, M. F., & Funk, C. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5897 · Cited by 523 · see citing works

The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo

Chiang, N., Serhan, C. N., Dahlén, S., Drazen, J. M., Hay, D. W. P., Rovati, G. E., Shimizu, T., Yokomizo, T., & Brink, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.4 · Cited by 464 · see citing works

A Novel P2X7 Receptor Activator, the Human Cathelicidin-Derived Peptide LL37, Induces IL-1β Processing and Release

Elssner, A., Duncan, M., Gavrilin, M. A., & Wewers, M. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4987 · Cited by 425 · see citing works

Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators

Merched, A. J., Ko, K., Gotlinger, K. H., Serhan, C. N., & Chan, L. (2008) · The FASEB Journal · doi:10.1096/fj.08-112201 · Cited by 414 · see citing works

The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm

Zhao, L., Moos, M. P. W., Gräbner, R., Pédrono, F., Fan, J., Kaiser, B., John, N. F. S., Schmidt, S., Spanbroek, R., Lötzer, K., et al. (2004) · Nature Medicine · doi:10.1038/nm1099 · Cited by 353 · see citing works

A novel method to determine the engulfment of apoptotic cells by macrophages using pHrodo succinimidyl ester

Miksa, M., Komura, H., Wu, R., Shah, K. G., & Wang, P. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.11.019 · Cited by 320 · see citing works

Ligand-specific conformational change of the G-protein–coupled receptor ALX/FPR2 determines proresolving functional responses

Cooray, S. N., Gobbetti, T., Montero‐Melendez, T., McArthur, S., Thompson, D., Clark, A. J. L., Flower, R. J., & Perretti, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308253110 · Cited by 301 · see citing works

Anti-Inflammatory Role of the Murine Formyl-Peptide Receptor 2: Ligand-Specific Effects on Leukocyte Responses and Experimental Inflammation

Dufton, N., Hannon, R., Brancaleone, V., Dalli, J., Patel, H., Gray, M., D’Acquisto, F., Buckingham, J. C., Perretti, M., & Flower, R. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903526 · Cited by 298 · see citing works

Resolvin D1 Limits Polymorphonuclear Leukocyte Recruitment to Inflammatory Loci

Norling, L. V., Dalli, J., Flower, R. J., Serhan, C. N., & Perretti, M. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.249508 · Cited by 252 · see citing works

Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement

Hayhoe, R. P. G., Kamal, A. M., Solito, E., Flower, R. J., Cooper, D., & Perretti, M. (2005) · Blood · doi:10.1182/blood-2005-08-3099 · Cited by 239 · see citing works

Lack of Neutrophil-Derived CRAMP Reduces Atherosclerosis in Mice

Döring, Y., Drechsler, M. D., Wantha, S., Kemmerich, K., Lievens, D., Vijayan, S., Gallo, R. L., Weber, C., & Soehnlein, O. (2012) · Circulation Research · doi:10.1161/circresaha.112.265868 · Cited by 230 · see citing works

Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7

Bäck, M., Powell, W. S., Dahlén, S., Drazen, J. M., Evans, J. F., Serhan, C. N., Shimizu, T., Yokomizo, T., & Rovati, G. E. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12665 · Cited by 217 · see citing works

Lipoxin A4 Inhibits IL-1β-Induced IL-6, IL-8, and Matrix Metalloproteinase-3 Production in Human Synovial Fibroblasts and Enhances Synthesis of Tissue Inhibitors of Metalloproteinases

Sodin‐Šemrl, S., Taddeo, B., Tseng, D., Varga, J., & Fiore, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2660 · Cited by 216 · see citing works

Matrix Metalloproteinases in Atherothrombosis

Bäck, M., Ketelhuth, D. F. J., & Agewall, S. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.12.002 · Cited by 196 · see citing works

Transforming Growth Factor–β Signaling in T Cells Promotes Stabilization of Atherosclerotic Plaques Through an Interleukin-17–Dependent Pathway

Gisterå, A., Robertson, A.-K. L., Andersson, J., Ketelhuth, D. F. J., Овчинникова, О. А., Nilsson, S. K., Lundberg, A. M., Li, M. O., Flavell, R. A., & Hansson, G. K. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006133 · Cited by 194 · see citing works

Defective Mer Receptor Tyrosine Kinase Signaling in Bone Marrow Cells Promotes Apoptotic Cell Accumulation and Accelerates Atherosclerosis

Ait-Oufella, H., Pouresmail, V., Simon, T., Blanc-Brude, O., Kinugawa, K., Merval, R., Offenstadt, G., Lesèche, G., Cohen, P. L., Tedgui, A., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.169078 · Cited by 187 · see citing works

FPR2/ALX receptor expression and internalization are critical for lipoxin A 4 and annexin‐derived peptide‐stimulated phagocytosis

MADERNA, P., Cottell, D. C., Toivonen, T., Dufton, N., Dalli, J., Perretti, M., & Godson, C. (2010) · The FASEB Journal · doi:10.1096/fj.10-159913 · Cited by 182 · see citing works

Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2

He, R. L., Zhou, J. H., Hanson, C. Z., Jia, C., Cheng, N., & Ye, R. D. (2008) · Blood · doi:10.1182/blood-2008-03-139923 · Cited by 169 · see citing works

Distinct Signaling Cascades Elicited by Different Formyl Peptide Receptor 2 (FPR2) Agonists

Cattaneo, F., Parisi, M., & Ammendola, R. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14047193 · Cited by 168 · see citing works

Neutrophil-Derived Cathelicidin Promotes Adhesion of Classical Monocytes

Wantha, S., Alard, J.-É., Megens, R. T. A., van der Does, A. M., Döring, Y., Drechsler, M. D., Pham, C. T. N., Wang, M., Wang, J.-M., Gallo, R. L., et al. (2013) · Circulation Research · doi:10.1161/circresaha.112.300666 · Cited by 152 · see citing works

Involvement of the Antimicrobial Peptide LL-37 in Human Atherosclerosis

Edfeldt, K., Agerberth, B., Rottenberg, M. E., Gudmundsson, G. H., Wang, X.-B., Mandal, K., Xu, Q., & Yan, Z. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000223901.08459.57 · Cited by 142 · see citing works

Association Between Serum Amyloid A Proteins and Coronary Artery Disease

Fyfe, A. I., Rothenberg, L. S., deBeer, F. C., Cantor, R. M., Rotter, J. I., & Lusis, A. J. (1997) · Circulation · doi:10.1161/01.cir.96.9.2914 · Cited by 137 · see citing works

Cutting Edge: A Critical Role for the G Protein-Coupled Receptor mFPR2 in Airway Inflammation and Immune Responses

Chen, K., Le, Y., Liu, Y., Gong, W., Ying, G., Huang, J., Yoshimura, T., Tessarollo, L., & Wang, J. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903022 · Cited by 117 · see citing works

Upregulation of the 5-Lipoxygenase Pathway in Human Aortic Valves Correlates With Severity of Stenosis and Leads to Leukotriene-Induced Effects on Valvular Myofibroblasts

Nagy, E., Andersson, D. C., Caidahl, K., Eriksson, M. J., Eriksson, P. O., Franco‐Cereceda, A., Hansson, G. K., & Bäck, M. (2011) · Circulation · doi:10.1161/circulationaha.110.966846 · Cited by 112 · see citing works

Leukotriene receptors in atherosclerosis

Bäck, M., & Hansson, G. K. (2006) · Annals of Medicine · doi:10.1080/07853890600982737 · Cited by 107 · see citing works

Proresolving and Tissue-Protective Actions of Annexin A1–Based Cleavage-Resistant Peptides Are Mediated by Formyl Peptide Receptor 2/Lipoxin A4 Receptor

Dalli, J., Consalvo, A. P., Ray, V., Filippo, C. D., D’Amico, M., Mehta, N., & Perretti, M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203000 · Cited by 105 · see citing works

Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis

Chen, K., Liu, M., Liu, Y., Yoshimura, T., Shen, W., Le, Y., Durum, S. K., Gong, W., Wang, C., Gao, J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65569 · Cited by 103 · see citing works

A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation

Brancaleone, V., Gobbetti, T., Cénac, N., Faouder, P. L., Colom, B., Flower, R. J., Vergnolle, N., Nourshargh, S., & Perretti, M. (2013) · Blood · doi:10.1182/blood-2013-04-496661 · Cited by 94 · see citing works

Expression of fatty acid-binding protein 4/aP2 is correlated with plaque instability in carotid atherosclerosis

Agardh, H. E., Folkersen, L., Ekstrand, J., Marcus, D., Swedenborg, J., Hedin, U., Gabrielsen, A., & Paulsson‐Berne, G. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02304.x · Cited by 81 · see citing works

Transforming growth factor-beta signaling in t cells promotes stabilization of atherosclerotic plaques through an interleukin-17 dependent pathway

Gisterå, A., Robertson, A.-K., Andersson, J., Ketelhuth, D. F. J., Овчинникова, О. А., Nilsson, S. K., Lundberg, A. M., Li, M. O., Flavell, R. A., & Hansson, G. K. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.05.233 · Cited by 78 · see citing works

Inhibitors of the 5-Lipoxygenase Pathway in Atherosclerosis

Bäck, M. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789058020 · Cited by 66 · see citing works

Thromboxane synthase expression and thromboxane A2 production in the atherosclerotic lesion

Gabrielsen, A., Qiu, H., Bäck, M., Hámberg, M., Hemdahl, A.-L., Agardh, H. E., Folkersen, L., Swedenborg, J., Hedin, U., Paulsson‐Berne, G., et al. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0621-6 · Cited by 55 · see citing works

Smooth muscle cells in human atherosclerosis: Proteomic profiling reveals differences in expression of Annexin A1 and mitochondrial proteins in carotid disease

Viiri, L. E., Full, L. E., Navin, T. J., Begum, S., Didangelos, A., Astola, N., Berge, R. K., Seppälä, I., Shalhoub, J., Franklin, I. J., et al. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.11.002 · Cited by 54 · see citing works

Oxidized LDL-Mediated Macrophage Survival Involves Elongation Factor-2 Kinase

Chen, J. H., Riazy, M., Smith, E. M., Proud, C. G., Steinbrecher, U. P., & Duronio, V. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.174599 · Cited by 42 · see citing works

Peptides derived from serum amyloid A prevent, and reverse, aortic lipid lesions in apoE−/− mice

Tam, S. P., Ancsin, J. B., Tan, R., & Kisilevsky, R. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500191-jlr200 · Cited by 38 · see citing works

Frequent Calcium Oscillations Lead to NFAT Activation in Human Immature Dendritic Cells

Vukcevic, M., Zorzato, F., Spagnoli, G. C., & Treves, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.066704 · Cited by 34 · see citing works

Role of formyl peptide receptor 2 on the serum amyloid A-induced macrophage foam cell formation

Lee, H. Y., Kim, S. D., Baek, S., Choi, J. H., & Bae, Y. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.03.002 · Cited by 28 · see citing works

ptx3, a key component of innate immunity, is induced by saa via fprl1-mediated signaling in HAECs

Dong, Z., An, F., Wu, T., Zhang, C., Zhang, M., Zhang, Y., An, G., & An, F. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23128 · Cited by 21 · see citing works

Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities

Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341 · see citing works

Targeting inflammation in atherosclerosis — from experimental insights to the clinic

Soehnlein, O., & Libby, P. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00198-1 · Cited by 1,042 · see citing works

Inflammation and plaque vulnerability

Hansson, G. K., Libby, P., & Tabas, I. A. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12406 · Cited by 809 · see citing works

More friend than foe: the emerging role of neutrophils in tissue repair

Peiseler, M., & Kubes, P. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124616 · Cited by 423 · see citing works

The role of non-resolving inflammation in atherosclerosis

Kasikara, C., Doran, A. C., Cai, B., & Tabas, I. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97950 · Cited by 266 · see citing works

Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function

Brennan, E. P., Kantharidis, P., Cooper, M. E., & Godson, C. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00454-y · Cited by 276 · see citing works

New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration

Serhan, C. N., Chiang, N., & Dalli, J. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.08.002 · Cited by 246 · see citing works

Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology

Sansbury, B. E., & Spite, M. R. (2016) · Circulation Research · doi:10.1161/circresaha.116.307308 · Cited by 226 · see citing works

Inflammation Resolution: Implications for Atherosclerosis

Doran, A. C. (2022) · Circulation Research · doi:10.1161/circresaha.121.319822 · Cited by 177 · see citing works

Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease

Pirault, J., & Bäck, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01273 · Cited by 167 · see citing works

Potential of anti-inflammatory agents for treatment of atherosclerosis

Chistiakov, D. A., Melnichenko, A. А., Grechko, A. V., Myasoedova, V. A., & Orekhov, A. N. (2018) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2018.01.008 · Cited by 169 · see citing works

Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease

Fredman, G., & Serhan, C. N. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00984-x · Cited by 160 · see citing works

Basic characteristics of the neutrophil receptors that recognize formylated peptides, a danger-associated molecular pattern generated by bacteria and mitochondria

Dahlgren, C., Gabl, M., Holdfeldt, A., Winther, M., & Forsman, H. F. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.04.014 · Cited by 141 · see citing works

ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages

Laguna-Fernandez, A., Checa, A., Carracedo, M., Artiach, G., Petri, M. H., Baumgartner, R., Forteza, M. J., Jiang, X., Andonova, T., Walker, M. E., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032801 · Cited by 141 · see citing works

Aspirin‐triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E^−/− mice

Petri, M. H., Laguna‐Fernandez, A., Arnardottir, H., Wheelock, C. E., Perretti, M., Hansson, G. K., & Bäck, M. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13707 · Cited by 120 · see citing works

Structure of formylpeptide receptor 2-Gi complex reveals insights into ligand recognition and signaling

Zhuang, Y., Liu, H., Zhou, X. E., Verma, R. K., de Waal, P. W., Jang, W., Xu, T.-H., Wang, L., Meng, X. M., Zhao, G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14728-9 · Cited by 112 · see citing works

Annexin-A1: Therapeutic Potential in Microvascular Disease

Purvis, G. S. D., Solito, E., & Thiemermann, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00938 · Cited by 107 · see citing works

Regulation of atherosclerotic plaque inflammation

Bäck, M., Weber, C., & Lutgens, E. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12367 · Cited by 94 · see citing works

Targeting immune cell recruitment in atherosclerosis

Döring, Y., van der Vorst, E. P. C., & Weber, C. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01023-z · Cited by 90 · see citing works

The resolution of inflammation through omega-3 fatty acids in atherosclerosis, intimal hyperplasia, and vascular calcification

Carracedo, M., Artiach, G., Arnardottir, H. H., & Bäck, M. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00767-y · Cited by 92 · see citing works

The resolvin D1 receptor GPR32 transduces inflammation resolution and atheroprotection

Arnardottir, H., Thul, S., Pawelzik, S., Karadimou, G., Artiach, G., Gallina, A. L., Mysdotter, V., Carracedo, M., Tarnawski, L., Caravaca, A. S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142883 · Cited by 85 · see citing works

Resolution Agonist 15-epi-Lipoxin A4 Programs Early Activation of Resolving Phase in Post-Myocardial Infarction Healing

Kain, V., Liu, F., Kozlovskaya, V., Ingle, K. A., Bolisetty, S., Agarwal, A., Khedkar, S. A., Prabhu, S. D., Kharlampieva, E., & Halade, G. V. (2017) · Scientific Reports · doi:10.1038/s41598-017-10441-8 · Cited by 80 · see citing works

Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35

Qin, C. X., Norling, L. V., Vecchio, E. A., Brennan, E. P., May, L. T., Wootten, D. L., Godson, C., Perretti, M., & Ritchie, R. H. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15919 · Cited by 76 · see citing works

Serum amyloid A and metabolic disease: evidence for a critical role in chronic inflammatory conditions

den Hartigh, L. D., May, K. S., Zhang, X.-S., Chait, A., & Blaser, M. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1197432 · Cited by 75 · see citing works

Serum amyloid A and atherosclerosis

Getz, G. S., Krishack, P. A., & Reardon, C. A. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000331 · Cited by 68 · see citing works

Lack of resolution sensor drives age-related cardiometabolic and cardiorenal defects and impedes inflammation-resolution in heart failure

Tourki, B., Kain, V., Pullen, A. B., Norris, P. C., Patel, N., Arora, P. K., Leroy, X., Serhan, C. N., & Halade, G. V. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.10.008 · Cited by 66 · see citing works

Resolution of vascular injury: Specialized lipid mediators and their evolving therapeutic implications

Wu, B., Mottola, G., Schaller, M. S., Upchurch, G. R., & Conte, M. S. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.07.005 · Cited by 64 · see citing works

Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potential

Maciuszek, M., Cacace, A., Brennan, E. P., Godson, C., & Chapman, T. M. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113167 · Cited by 63 · see citing works

Aspirin-triggered 15-epi-lipoxin A4 signals through FPR2/ALX in vascular smooth muscle cells and protects against intimal hyperplasia after carotid ligation

Petri, M. H., Laguna-Fernandez, A., Tseng, C.-N., Hedin, U., Perretti, M., & Bäck, M. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.11.010 · Cited by 60 · see citing works

Beyond host defense and tissue injury: the emerging role of neutrophils in tissue repair

Rizo-Téllez, S. A., & Filep, J. G. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00652.2023 · Cited by 62 · see citing works

Resolution of Inflammation Through the Lipoxin and ALX/FPR2 Receptor Pathway Protects Against Abdominal Aortic Aneurysms

Petri, M. H., Thul, S., Andonova, T., Liljeqvist, M. L., Jin, H. H., Skenteris, N.-T., Arnardottir, H. H., Mäegdefessel, L., Caidahl, K., Perretti, M., et al. (2018) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2018.08.005 · Cited by 52 · see citing works

Mitochondria‐derived damage‐associated molecular patterns and inflammation in the ischemic‐reperfused heart

Torp, M., Vaage, J., & Stensløkken, K. (2023) · Acta Physiologica · doi:10.1111/apha.13920 · Cited by 53 · see citing works

Formyl peptide receptor 2 regulates monocyte recruitment to promote intestinal mucosal wound repair

Birkl, D., O’Leary, M. N., Quirós, M., Azcutia, V., Schaller, M. A., Reed, M., Nishio, H., Keeney, J. N., Neish, A. S., Lukacs, N. W., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901163r · Cited by 49 · see citing works

Formyl peptide receptor 2 is an emerging modulator of inflammation in the liver

Lee, C., Han, J., & Jung, Y. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00941-1 · Cited by 52 · see citing works

Formyl Peptide Receptors in Cellular Differentiation and Inflammatory Diseases

Lee, H. Y., Lee, M., & Bae, Y. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25877 · Cited by 48 · see citing works

Personalized Nutrition and -Omics

Chaudhary, N., Kumar, V., Sangwan, P., Pant, N. C., Saxena, A., Joshi, S., & Yadav, A. N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-100596-5.22880-1 · Cited by 48 · see citing works

Targeting non-coding RNAs in unstable atherosclerotic plaques: Mechanism, regulation, possibilities, and limitations

Li, X., Yang, Y., Wang, Z., Jiang, S., Meng, Y., Song, X., Zhao, L., Zou, L., Li, M., & Yu, T. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.62506 · Cited by 47 · see citing works

Regulation of Inflammation and Oxidative Stress by Formyl Peptide Receptors in Cardiovascular Disease Progression

Caso, V. M., Manzo, V., Cimmino, T. P., Conti, V., Caso, P., Esposito, G., Russo, V., Filippelli, A., Ammendola, R., & Cattaneo, F. (2021) · Life · doi:10.3390/life11030243 · Cited by 45 · see citing works

Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model

Wu, B., Werlin, E. C., Chen, M., Mottola, G., Chatterjee, A., Lance, K. D., Bernards, D. A., Sansbury, B. E., Spite, M. R., Desai, T. A., et al. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2018.05.206 · Cited by 44 · see citing works

The G-protein coupled receptor ChemR23 determines smooth muscle cell phenotypic switching to enhance high phosphate-induced vascular calcification

Carracedo, M., Artiach, G., Witasp, A., Clària, J., Carlström, M., Laguna-Fernández, A., Stenvinkel, P., & Bäck, M. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy316 · Cited by 44 · see citing works

The resolvin D2 – GPR18 axis is expressed in human coronary atherosclerosis and transduces atheroprotection in apolipoprotein E deficient mice

Bardin, M., Pawelzik, S., Lagrange, J., Mahdi, A., Arnardottir, H. H., Regnault, V., Fève, B., Lacolley, P. J., Michel, J., Mercier, N., et al. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115075 · Cited by 43 · see citing works

Single-Cell Analyses Identify Dysfunctional CD16+ CD8 T Cells in Smokers

Martos, S. N., Campbell, M. R., Lozoya, O. A., Wang, X., Bennett, B. D., Thompson, I. J. B., Wan, M., Pittman, G. S., & Bell, D. A. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100054 · Cited by 42 · see citing works

Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy

Kim, A. S., & Conte, M. S. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.011 · Cited by 41 · see citing works

Formyl peptide receptor 2 and heart disease

Lupisella, J. A., Shirude, P. S., Wurtz, N. R., & Garcia, R. A. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101602 · Cited by 39 · see citing works

Lipoxin-mediated signaling: ALX/FPR2 interaction and beyond

Sánchez‐García, S., Jaén, R. I., Fernández‐Velasco, M., Delgado, C., Boscá, L., & Prieto, P. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106982 · Cited by 39 · see citing works

Annexin A protein family in atherosclerosis

Li, Y., Wang, Y., Huang, L., Zhao, Y.-Y., Chen, L.-H., & Zhang, C. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.05.009 · Cited by 35 · see citing works

The atheroprotective role of lipoxin A4 prevents oxLDL-induced apoptotic signaling in macrophages via JNK pathway

Mai, J., Liu, W., Fang, Y., Zhang, S., Qiu, Q., Yang, Y., Wang, X., Huang, T., Zhang, H., Xie, Y., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.09.025 · Cited by 34 · see citing works

Targeting formyl peptide receptors to facilitate the resolution of inflammation

Filep, J. G., Sekheri, M., & Kebir, D. E. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.06.025 · Cited by 35 · see citing works

Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling

del Campo, L. S. D., Rodrigues‐Díez, R., Salaíces, M., Briones, A. M., & García‐Redondo, A. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073592 · Cited by 33 · see citing works

Apoproteins E, A-I, and SAA in Macrophage Pathobiology Related to Atherogenesis

Getz, G. S., & Reardon, C. A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00536 · Cited by 31 · see citing works

Interferon-β regulates proresolving lipids to promote the resolution of acute airway inflammation

Sekheri, M., Rizo-Téllez, S. A., Othman, A., Kebir, D. E., & Filep, J. G. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2201146119 · Cited by 32 · see citing works

Diabetic Retinopathy in the Spontaneously Diabetic Torii Rat: Pathogenetic Mechanisms and Preventive Efficacy of Inhibiting the Urokinase-Type Plasminogen Activator Receptor System

Cammalleri, M., Monte, M. D., Locri, F., Marsili, S., Lista, L., ROSA, M. D., Pavone, V., Rusciano, D., & Bagnoli, P. (2017) · Journal of Diabetes Research · doi:10.1155/2017/2904150 · Cited by 29 · see citing works

Opposing Effects on Vascular Smooth Muscle Cell Proliferation and Macrophage-induced Inflammation Reveal a Protective Role for the Proresolving Lipid Mediator Receptor ChemR23 in Intimal Hyperplasia

Artiach, G., Carracedo, M., Clària, J., Laguna-Fernández, A., & Bäck, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01327 · Cited by 29 · see citing works

G-Protein Coupled Receptor Targeting on Myeloid Cells in Atherosclerosis

van der Vorst, E. P. C., Peters, L. J. F., Müller, M., Gencer, S., Yan, Y., Weber, C., & Döring, Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00531 · Cited by 29 · see citing works

Lipoxins modulate neutrophil oxidative burst, integrin expression and lymphatic transmigration differentially in human health and atherosclerosis

Kraft, J. D., Blomgran, R., Bergström, I., Soták, M., Clark, M., Rani, A., Rajan, M. R., Dalli, J., Nyström, S., Quiding‐Järbrink, M., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101219rr · Cited by 29 · see citing works

Sexually Dimorphic Relationships Among Saa3 (Serum Amyloid A3), Inflammation, and Cholesterol Metabolism Modulate Atherosclerosis in Mice

Chait, A., Wang, S., Goodspeed, L., Gomes, D. J., Turk, K. E., Wietecha, T., Tang, J., Storey, C., O’Brien, K. D., Rubinow, K. B., et al. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316066 · Cited by 28 · see citing works

Molecular Pharmacology of Inflammation Resolution in Atherosclerosis

Kotlyarov, S. N., & Котлярова, А. А. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094808 · Cited by 30 · see citing works

Resolvin D1/N-formyl peptide receptor 2 ameliorates paclitaxel-induced neuropathic pain through the activation of IL-10/Nrf2/HO-1 pathway in mice

Su, C., Zhang, J., Zhao, F., Xu, D., Pan, J., & Liu, T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1091753 · Cited by 27 · see citing works

Extrinsic and intrinsic modulators of inflammation-resolution signaling in heart failure

Rao, A., Gupta, A., Kain, V., & Halade, G. V. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00276.2023 · Cited by 26 · see citing works

Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis

Salazar, J. J., Pírela, D., Nava, M., Castro, A. V., Angarita, L., Parra, H., Durán‐Agüero, S., Rojas-Gómez, D. M., Galbán, N., Áñez, R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063133 · Cited by 26 · see citing works

Bioinformatics and Next-Generation Data Analysis for Identification of Genes and Molecular Pathways Involved in Subjects with Diabetes and Obesity

Ganekal, P., Vastrad, B. M., Kavatagimath, S., Vastrad, C. M., & Kotrashetti, S. (2023) · Medicina · doi:10.3390/medicina59020309 · Cited by 24 · see citing works

Lipoxin A4 improves cardiac remodeling and function in diabetes-associated cardiac dysfunction

Fu, T., Mohan, M., Bose, M., Brennan, E. P., Kiriazis, H., Deo, M., Nowell, C. J., Godson, C., Cooper, M. E., Zhao, P., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02501-x · Cited by 23 · see citing works

Acute-serum amyloid A and A-SAA-derived peptides as formyl peptide receptor (FPR) 2 ligands

Salama, S. A., Gouwy, M., Damme, J. V., & Struyf, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1119227 · Cited by 22 · see citing works

Bioinformatics and System Biological Approaches for the Identification of Genetic Risk Factors in the Progression of Cardiovascular Disease

Barua, J. D., Omit, S. B. S., Rana, H. K., Podder, N. K., Chowdhury, U. N., & Rahman, M. H. (2022) · Cardiovascular Therapeutics · doi:10.1155/2022/9034996 · Cited by 20 · see citing works

The Role of Serum Resolvin D1 Levels in Determining the Presence and Prognosis of ST-Segment Elevation Myocardial Infarction

Karayiğit, O., Nurkoç, S. G., Başyiğit, F., & Kızıltunç, E. (2022) · Medical Principles and Practice · doi:10.1159/000527064 · Cited by 19 · see citing works

DAMP signaling networks: from receptors to diverse pathophysiological functions

Chen, R., Zou, J., Zhong, X. Y., Liu, J., Kang, R., & Tang, D. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.07.047 · Cited by 20 · see citing works

Prognostic impacts of Lipoxin A4 in patients with acute myocardial infarction: A prospective cohort study

Chen, R., Li, J., Zhou, J., Wang, Y., Zhao, X., Li, N., Liu, W., Liu, C., Zhou, P., Chen, Y., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106618 · Cited by 18 · see citing works

Pro-resolving lipid mediators in diseases: exploring the molecular basis and clinical implication

Li, C., Wang, Z., Yang, Y., Jiang, Q., Jiang, Y., Xiao, J., Shen, L., Wu, W., & Li, C. (2026) · Molecular Biomedicine · doi:10.1186/s43556-025-00400-5 · Cited by 19 · see citing works

The Role of Endogenous Specialized Proresolving Mediators in Mast Cells and Their Involvement in Inflammation and Resolution

Fukuishi, N., Takahama, K., Kurosaki, H., Ono, S., & Asai, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041491 · Cited by 17 · see citing works

15-epi-lipoxin A4 inhibits TNF-α-induced tissue factor expression via the PI3K/AKT/ NF-κB axis in human umbilical vein endothelial cells

Chen, Y., Zheng, Y., Xin, L., Zhong, S., Liu, A., Lai, W., Liu, L., Lin, C., Liao, C., Zeng, J., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109099 · Cited by 16 · see citing works

Potential Target Genes in the Development of Atrial Fibrillation: A Comprehensive Bioinformatics Analysis

Liu, L., Yu, Y., Hu, L., Dong, Q., Hu, F., Zhu, L., Liang, Q., Yu, L., Bao, H.-H., & Cheng, X. (2021) · Medical Science Monitor · doi:10.12659/msm.928366 · Cited by 14 · see citing works

Lipoxins as Modulators of Diseases

Saqib, U., Pandey, M., Vyas, A., Patidar, P., Hajela, S., Ali, A., Tiwari, M., Sarkar, S., Yadav, N., Patel, S. S., et al. (2025) · Cells · doi:10.3390/cells14161244 · Cited by 13 · see citing works

Differential regulation of monocytic expression of leukotriene and lipoxin receptors

Petri, M. H., Thul, S., Овчинникова, О. А., & Bäck, M. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.07.005 · Cited by 13 · see citing works

Exploiting oxidized lipids and the lipid‐binding GPCRs against cardiometabolic diseases

Guimarães, R. C., Gonçalves, T. T., & Leiria, L. O. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15321 · Cited by 13 · see citing works

Specialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca2+ Handling and NRF2 Activation

Val‐Blasco, A., Prieto, P., Jaén, R. I., Fernández, M. G., Pajares, M., Doménech, N., Terrón, V., Tamayo, M., Jorge, I., Vázquez, J., et al. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.01.009 · Cited by 13 · see citing works

DHA, RvD1, RvD5, and MaR1 reduce human coronary arteries contractions induced by PGE2

Bouhadoun, A., Manikpurage, H. D., Deschildre, C., Zalghout, S., Dubourdeau, M., Urbach, V., Ho‐Tin‐Noé, B., Deschamps, L., Michel, J., Longrois, D., et al. (2022) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2022.106700 · Cited by 13 · see citing works

Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease

Spite, M. R., & Fredman, G. (2023) · Advances in pharmacology · doi:10.1016/bs.apha.2022.12.005 · Cited by 13 · see citing works

Specialized proresolution mediators in the bladder: annexin-A1 normalizes inflammation and bladder dysfunction during bladder outlet obstruction

Hughes, F. M., Harper, S. N., Nosé, B. D., Allkanjari, A., Zheng, M., Jin, H., & Purves, J. T. (2021) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00205.2021 · Cited by 14 · see citing works

wRAPping Up Early Monocyte and Neutrophil Recruitment in Atherogenesis via AnnexinA1/FPR2 Signaling

Butcher, M. J., & Galkina, E. (2015) · Circulation Research · doi:10.1161/circresaha.115.305920 · Cited by 13 · see citing works

Lipoxin and glycation in SREBP signaling: Insight into diabetic cardiomyopathy and associated lipotoxicity

Thakur, M., & Tupe, R. S. (2022) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2022.106698 · Cited by 13 · see citing works

Resolvin D1 attenuates Ang II-induced hypertension in mice by inhibiting the proliferation, migration and phenotypic transformation of vascular smooth muscle cells by blocking the RhoA/mitogen-activated protein kinase pathway

Cheng, W., Zhang, J., Peng, S., Liu, J., Xu, Y. Q., Zhao, M., Xu, S., Pan, W. D., Yin, Z., Zheng, Z., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003610 · Cited by 10 · see citing works

Basic Mechanisms of Atherosclerosis

Bäck, M., & Hansson, G. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42880-4.00004-2 · Cited by 12 · see citing works

Circ‐ADAM9 Knockdown Reduces Insulin Resistance and Placental Injury in Diabetic Mice via MAPK Pathway Inactivation

Zhao, A., Yang, Y., Yang, Y., Chi, Z., & Sun, Y. (2024) · American Journal of Reproductive Immunology · doi:10.1111/aji.70017 · Cited by 9 · see citing works

Contribution of Sex Differences to Development of Cardiovascular Disease in Metabolic-Associated Steatotic Liver Disease (MASLD)

Taylor, L. C., Arthur, G., Cruz, M. D. C., Stec, D. E., & Badmus, O. O. (2024) · International Journal of Translational Medicine · doi:10.3390/ijtm4040052 · Cited by 9 · see citing works

Increased atherogenic index in the general hearing loss population

Zhang, H., Wang, D., Ma, H., Ren, Y., Li, C., Zheng, Y.-H., Dai, X., Yang, L., & Xu, L. (2020) · Open Medicine · doi:10.1515/med-2020-0003 · Cited by 9 · see citing works

Inflammation-resolution signalling in cardiac repair, remodelling, and heart failure

Halade, G. V., Bäck, M., & Kain, V. (2025) · European Heart Journal Open · doi:10.1093/ehjopen/oeaf157 · Cited by 8 · see citing works

Unleashing the power of formyl peptide receptor 2 in cardiovascular disease

Prevete, N., Poto, R., Marone, G., & Varricchi, G. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156298 · Cited by 8 · see citing works

Proresolving receptor tames inflammation in atherosclerosis

Mena, H. A., & Spite, M. R. (2021) · Journal of Clinical Investigation · doi:10.1172/jci155240 · Cited by 8 · see citing works

Posing the rationale for synthetic lipoxin mimetics as an adjuvant treatment to gold standard atherosclerosis therapies

Millar, B., & de Gaetano, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1125858 · Cited by 6 · see citing works

Design, synthesis, and biological evaluation of novel pyrrolidinone small-molecule Formyl peptide receptor 2 agonists

Maciuszek, M., Ortega‐Gómez, A., Maas, S. L., Garrido‐Mesa, J., Ferraro, B., Perretti, M., Merritt, A. T., Nicolaes, G. A. F., Soehnlein, O., & Chapman, T. M. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113805 · Cited by 6 · see citing works

Immune-Related Genes in the Pathogenesis of Atherosclerosis: Based on Sex Differences

Zhang, P., Lin, H., Guo, Y. P., Peng, F., & Meng, L. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s429247 · Cited by 5 · see citing works

Differential gene expression and miRNA regulatory network in coronary slow flow

Sun, L., Wang, J., Lei, J., Zhang, Y., Zhang, Y., Zhang, Y., & Xing, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-58745-w · Cited by 5 · see citing works

ALX-chemy: adding spice to the inflammatory soup of atherosclerosis

Libby, P. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu245 · Cited by 5 · see citing works

Formyl peptide receptor 1 and its antagonist T0080 in atherosclerosis

Li, Y.-J., Zhao, X., Wu, S., Yao, N., Zhang, X., Liu, Y., Tian, X., Li, Y., Gao, B., Johnston, S. C., et al. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-025-01506-7 · Cited by 4 · see citing works

Mesenchymal Stem Cells and Formyl Peptide Receptor 2 Activity in Hyperoxia-Induced Lung Injury in Newborn Mice

Kim, Y., Ahn, S. Y., Sung, D. K., Chang, Y. S., & Park, W. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810604 · Cited by 4 · see citing works

Formyl peptide receptor 2: a potential therapeutic target for inflammation-related diseases

Wang, J., Miao, Z., Gao, Y., Xie, Z., Liu, M., & Zou, W. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00704-x · Cited by 4 · see citing works

Fine-tuning inflammation-resolution programs

Fredman, G., Sadhu, S., & Rymut, N. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000351 · Cited by 4 · see citing works

Dynamic changes in proresolving lipid mediators and their receptors following acute vascular injury in male rats

Kagaya, H., Kim, A. S., Chen, M., Lin, P., Yin, X., Spite, M. R., & Conte, M. S. (2024) · Physiological Reports · doi:10.14814/phy2.16178 · Cited by 3 · see citing works

Identification of crucial genes that induce coronary atherosclerosis through endothelial cell dysfunction in AMI-identifying hub genes by WGCNA.

Xiao, S., & Kuang, C. (2022) · PubMed Central · Cited by 4 · see citing works

Whole-Genome Linkage Scan Combined With Exome Sequencing Identifies Novel Candidate Genes for Carotid Intima-Media Thickness

Vojinović, D., Kavousi, M., Ghanbari, M., Brouwer, R. W. W., van Rooij, J., van den Hout, M. C. G. N., Kraaij, R., van IJcken, W. F. J., Uitterlinden, A. G., van Duijn, C. M., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00420 · Cited by 4 · see citing works

development and plaque stability

Petri, M. H., Gonzalez-diez, M., Paulsson‐Berne, G., & Hansson, G. K. (2015)

ALX-chemy: adding spice to the inflammatory soup of atherosclerosis

Libby, P. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu245 · Cited by 5 · see citing works

The role of FPR2/ALX in the vascular wall

Petri, M. H. (2015) · Figshare

EDITORIAL ALX-chemy: adding spice to the inflammatory soup of atherosclerosis

Libby, P. (2014)

Leukocyte chemoattractant receptor FPR2 may accelerate atherogenesis

Wan, W., & Gao, J. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.04.014 · Cited by 5 · see citing works